Despite its hurried approval late last year, we are repeatedly told the Moderna COVID vaccine has been thoroughly tested and proven safe and effective. That’s a lie. The clinical trial research for this drug is woefully incomplete, contains a number of curious anomalies, and shows the vaccine has a far higher rate of side effects. And – as with the Pfizer-BioNtech and Oxford-AstraZeneca vaccine research – it dismally fails to provide even remotely credible evidence that a COVID vaccine can save even a single life.
Moderna is an overpromising, underdelivering company that had previously failed to bring even a single drug to market. Despite this poor track record, it became the first company to get US federal backing for COVID vaccine development. It’s vaccine is based on unproven and potentially dangerous technology, yet was granted “emergency use” authorization in December 2020. Moderna has also become a stock market darling, with a market capitalization that simply cannot be justified by its current revenue prospects.